113. 筋ジストロフィー Muscular dystrophy Clinical trials / Disease details


臨床試験数 : 646 薬物数 : 471 - (DrugBank : 105) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 170

  
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05412394
(ClinicalTrials.gov)
April 30, 20212/2/2022Once Weekly Infant Corticosteroid Trial for DMDPhase-2 Trial of 5mg/kg/Week Prednisolone in Young Boys With DMDDuchenne Muscular DystrophyDrug: PrednisoloneAnne M. ConnollyAnn & Robert H Lurie Children's Hospital of Chicago;Children's Hospital Medical Center, CincinnatiRecruiting1 Month30 MonthsMale26Phase 4United States
2NCT03777319
(ClinicalTrials.gov)
December 5, 201810/12/2018Spironolactone Versus Prednisolone in DMDA Randomized Open Label Trial of Spironolactone Versus Prednisolone in Corticosteroid-naïve Boys With DMDMuscular Dystrophy, DuchenneDrug: Spironolactone;Drug: PrednisoloneKevin FlaniganMuscular Dystrophy AssociationTerminated4 Years7 YearsMale2Phase 1United States
3NCT02167217
(ClinicalTrials.gov)
April 17, 20143/2/2014Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular DystrophyPhase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular DystrophyDuchenne Muscular DystrophyDrug: PrednisoloneWashington University School of MedicineNationwide Children's Hospital;Feinberg School of Medicine, Northwestern University;University of Texas Southwestern Medical Center;University of California, Davis;Nemours Hospital, Orlando, FLCompleted1 Month30 MonthsMale25Phase 2United States